The U.S. Food and Drug Administration has approved a new drug to treat Alzheimer’s disease. It was approved by the Food and Drug Administration (FDA).
It’s 20 years since the introduction of this drug against Alzheimer’s, and this is really good news for the 6.2 million people with Alzheimer’s disease in the United States and Alzheimer’s worldwide.
Alzheimer’s is a disease that affects the brain. This drug is called ‘aducanumab’. In Alzheimer’s disease, memory loss, impaired thinking ability, and brain dysfunction occur. If so, it cannot be restored.
Alzheimer’s symptoms occur in adults over the age of 60, but even people in their 30s and 40s tend to develop Alzheimer’s. The new drug was developed by Biogen Biogen Biotechnology in Massachusetts, USA.
Doctors say that when people with Alzheimer’s are diagnosed early and given the drug ‘adukenumab’, the sticky protein deposits called ‘amyloid beta’ in their brains are removed. Medical researchers explain that adducenumab is not a cure for Alzheimer’s, and that it can be given and cured at the first sign of Alzheimer’s.Leave a comment